California Scientists, Biotech Firms Welcome Stem Cell Policy Changes
California scientists and biotechnology companies are preparing for new stem cell research opportunities when President-elect Barack Obama takes office in January, the Contra Costa Times reports.
The Bush administration has limited federal funding for stem cell research.
Stem cells developed prior to 2001 are not restricted by research funding, but only 21 of those lines are available and most are created in ways that prevent use in humans.
Michael West -- CEO of Biotime, a biotech firm in Alameda -- said President Bush's stem cell policies have hindered research efforts. He added, "Many companies, both smaller biotech and larger Pharma companies, have been reluctant to invest in the technology due to the uncertain federal policy."
Obama has indicated that he plans to issue an executive order to reverse the Bush administration's stem cell policy. Under the new administration, NIH would be able to provide additional grant funding for research (Morrill, Contra Costa Times, 11/17).This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.